Brown Hannah J, Kuhar Hannah N, Plitt Max A, Husain Inna, Batra Pete S, Tajudeen Bobby A
Rush Medical College, Chicago, IL, USA.
Department of Otolaryngology, Ohio State University Medical Center, Columbus, OH, USA.
Ann Otol Rhinol Laryngol. 2020 Sep;129(9):886-893. doi: 10.1177/0003489420921424. Epub 2020 May 11.
This study explored the impact of laryngopharyngeal reflux (LPR) on quality-of-life outcomes captured by Sino-Nasal Outcome Test (SNOT-22) and Reflux Symptom Index (RSI) in patients with chronic rhinosinusitis (CRS) and patients with symptoms of LPR.
In a retrospective chart review, SNOT-22 and RSI scores were analyzed in patients seen at a tertiary care center with CRS, LPR, or both CRS and LPR. SNOT-22 items were grouped into sleep, nasal, otologic, and emotional symptom subdomains.
A total of 138 patients (36 with CRS alone, 60 with LPR alone, and 42 with both CRS and LPR) were included. Compared to patients with CRS alone, those with CRS and LPR (CRS+LPR) had higher SNOT-22 total (50.54 ± 19.53 vs 35.31 ± 20.20, < .001), sleep (19.61 ± 9.31 vs 14.42 ± 10.34, < .022), nasal (17.38 ± 7.49 vs 11.11 ± 8.52, < .001), otologic subdomains (9.17 ± 5.07 vs 5.53 ± 5.14, < .002), and RSI (22.06 ± 9.42 vs 10.75 ± 8.43, < .003). Patients with LPR alone had higher RSI compared to those with CRS (18.48 ± 9.77 vs 10.75 ± 8.43, < .037). RSI and SNOT-22 scores were positively correlated irrespective of patient group (R = 0.289, = .003).
Compared to patients with CRS or LPR alone, those with CRS+LPR demonstrated higher RSI and total and subdomain SNOT-22 scores. Patients with LPR alone had elevated SNOT-22 despite absent endoscopic evidence of sinusitis.
本研究探讨了喉咽反流(LPR)对慢性鼻-鼻窦炎(CRS)患者以及有LPR症状患者的生活质量的影响,这些影响通过鼻-鼻窦结局测试(SNOT-22)和反流症状指数(RSI)来体现。
在一项回顾性病历审查中,分析了在一家三级医疗中心就诊的CRS患者、LPR患者或同时患有CRS和LPR的患者的SNOT-22和RSI评分。SNOT-22项目被分为睡眠、鼻部、耳部和情绪症状子领域。
共纳入138例患者(36例仅患有CRS,60例仅患有LPR,42例同时患有CRS和LPR)。与仅患有CRS的患者相比,同时患有CRS和LPR(CRS+LPR)的患者SNOT-22总分更高(50.54±19.53对35.31±20.20,P<.001),睡眠子领域得分更高(19.61±9.31对14.42±10.34,P<.022),鼻部子领域得分更高(17.38±7.49对11.11±8.52,P<.001),耳部子领域得分更高(9.17±5.07对5.53±5.14,P<.002),RSI得分更高(22.06±9.42对10.75±8.43,P<.003)。仅患有LPR的患者比患有CRS的患者RSI更高(18.48±9.77对10.75±8.43,P<.037)。无论患者组如何,RSI和SNOT-22评分均呈正相关(R=×0.289,P=.003)。
与仅患有CRS或LPR的患者相比,同时患有CRS+LPR的患者RSI以及SNOT-22总分和各子领域得分更高。仅患有LPR的患者尽管鼻窦镜检查没有鼻窦炎的证据,但SNOT-22得分升高。